,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,48377,971,Therapeutic Target Database (TTD),Oxalic Acid,D0U7BY,Oxalic Acid,https://idrblab.net/ttd/data/drug/details/D0U7BY,T85943,Proto-oncogene c-Src (SRC),https://idrblab.net/ttd/data/target/details/T85943,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
1,112345,971,BindingDB,Oxalic Acid,14674,Fragment 4,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14674,1558,Proto-oncogene tyrosine-protein kinase Src (aa 145-252),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1558,,,,,,,,IC50 (nM),>40000000,PMID:14613321,https://www.ncbi.nlm.nih.gov/pubmed/14613321,14613321,,
2,112346,971,DrugBank,Oxalic Acid,DB03902,Oxalic Acid,https://www.drugbank.ca/drugs/DB03902,BE0000838,Proto-oncogene tyrosine-protein kinase Src,https://www.drugbank.ca/bio_entities/BE0000838,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,"Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.|Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
3,112347,971,DrugBank,Oxalic Acid,DB03902,Oxalic Acid,https://www.drugbank.ca/drugs/DB03902,BE0001042,Solute carrier organic anion transporter family member 2B1,https://www.drugbank.ca/bio_entities/BE0001042,O94956,Solute carrier organic anion transporter family member 2B1 ,11309.0,SLCO2B1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:12724351,https://www.ncbi.nlm.nih.gov/pubmed/12724351,12724351,,"Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I: Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther. 2003 Aug;306(2):703-8. Epub 2003 Apr 30."
4,112348,971,DrugBank,Oxalic Acid,DB03902,Oxalic Acid,https://www.drugbank.ca/drugs/DB03902,BE0003645,Solute carrier family 22 member 8,https://www.drugbank.ca/bio_entities/BE0003645,Q8TCC7,Solute carrier family 22 member 8,9376.0,SLC22A8,9606.0,Homo sapiens (human),Substrate,,,PMID:10049739,https://www.ncbi.nlm.nih.gov/pubmed/10049739,10049739,,"Race JE, Grassl SM, Williams WJ, Holtzman EJ: Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun. 1999 Feb 16;255(2):508-14."
5,124170,971,Toxin and Toxin Target Database (T3DB),Oxalic Acid,T3D0856,Oxalic acid,http://www.t3db.ca/toxins/T3D0856,BE0002257,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002257,Q99643,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",6391.0,SDHC,9606.0,Homo sapiens (human),Oxalic acid is a competitive inhibitor of succinate dehydrogenase. (A220),,,PMID:6318974,https://www.ncbi.nlm.nih.gov/pubmed/6318974,6318974,,
6,196367,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D010070,Oxalates,https://ctdbase.org/detail.go?type=chem&acc=D010070,2596,GAP43,https://ctdbase.org/detail.go?type=gene&acc=2596,,,2596.0,GAP43,9606.0,Homo sapiens (human),Oxalates inhibits the reaction [NGF protein results in increased expression of GAP43 protein],,,PMID:21981408,https://www.ncbi.nlm.nih.gov/pubmed/21981408,21981408,,
7,196368,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D010070,Oxalates,https://ctdbase.org/detail.go?type=chem&acc=D010070,4586,MUC5AC,https://ctdbase.org/detail.go?type=gene&acc=4586,,,4586.0,MUC5AC,9606.0,Homo sapiens (human),Oxalates results in increased expression of MUC5AC mrna|slc26a9 affects the reaction [oxalates results in increased expression of MUC5AC mrna]|[tp53 gene polymorphism results in increased susceptibility to [smoke results in increased abundance of oxalates]] which results in increased expression of MUC5AC mRNA,,,PMID:35072516,https://www.ncbi.nlm.nih.gov/pubmed/35072516,35072516,,
8,196937,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D010070,Oxalates,https://ctdbase.org/detail.go?type=chem&acc=D010070,4803,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803.0,NGF,9606.0,Homo sapiens (human),[magnesium sulfate co-treated with calcium gluconate] inhibits the reaction [oxalates inhibits the reaction [NGF protein results in increased transport of calcium]]|oxalates inhibits the reaction [NGF protein results in increased transport of calcium]|[magnesium sulfate co-treated with calcium gluconate] inhibits the reaction [oxalates results in decreased susceptibility to NGF protein]|oxalates results in decreased susceptibility to NGF protein|oxalates inhibits the reaction [NGF protein results in increased expression of GAP43 protein],,,PMID:21981408,https://www.ncbi.nlm.nih.gov/pubmed/21981408,21981408,,
9,196938,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D010070,Oxalates,https://ctdbase.org/detail.go?type=chem&acc=D010070,10861,SLC26A1,https://ctdbase.org/detail.go?type=gene&acc=10861,,,10861.0,SLC26A1,9606.0,Homo sapiens (human),SLC26A1 affects the localization of oxalates|slc26a1 affects the transport of oxalates,,,PMID:20160351,https://www.ncbi.nlm.nih.gov/pubmed/20160351,20160351,,
10,196939,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D010070,Oxalates,https://ctdbase.org/detail.go?type=chem&acc=D010070,65010,SLC26A6,https://ctdbase.org/detail.go?type=gene&acc=65010,,,65010.0,SLC26A6,9606.0,Homo sapiens (human),SLC26A6 protein results in increased transport of oxalates|estradiol inhibits the reaction [SLC26A6 protein results in increased transport of oxalates],,,PMID:35500753,https://www.ncbi.nlm.nih.gov/pubmed/35500753,35500753,,
11,196940,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D010070,Oxalates,https://ctdbase.org/detail.go?type=chem&acc=D010070,115019,SLC26A9,https://ctdbase.org/detail.go?type=gene&acc=115019,,,115019.0,SLC26A9,9606.0,Homo sapiens (human),SLC26A9 affects the reaction [oxalates results in increased expression of MUC5AC mrna]|slc26a9 affects the reaction [oxalates results in increased expression of SPDEF mrna],,,PMID:35072516,https://www.ncbi.nlm.nih.gov/pubmed/35072516,35072516,,
12,196941,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D010070,Oxalates,https://ctdbase.org/detail.go?type=chem&acc=D010070,25803,SPDEF,https://ctdbase.org/detail.go?type=gene&acc=25803,,,25803.0,SPDEF,9606.0,Homo sapiens (human),Oxalates results in increased expression of SPDEF mrna|slc26a9 affects the reaction [oxalates results in increased expression of SPDEF mrna],,,PMID:35072516,https://www.ncbi.nlm.nih.gov/pubmed/35072516,35072516,,
13,196942,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D010070,Oxalates,https://ctdbase.org/detail.go?type=chem&acc=D010070,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),[TP53 gene polymorphism results in increased susceptibility to [smoke results in increased abundance of oxalates]] which results in increased expression of MUC5AC mRNA,,,PMID:35072516,https://www.ncbi.nlm.nih.gov/pubmed/35072516,35072516,,
14,196943,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10116.0,Rattus norvegicus (Norway rat),Zinc inhibits the reaction [oxalic acid results in decreased activity of AHR protein]|oxalic acid results in decreased activity of AHR protein,,,PMID:2160969,https://www.ncbi.nlm.nih.gov/pubmed/2160969,2160969,,
15,196944,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Sulfaphenazole inhibits the reaction [oxalic acid results in increased expression of BAX mrna]|oxalic acid results in increased expression of BAX mrna|[butyric acid co-treated with sulfaphenazole] inhibits the reaction [oxalic acid results in increased expression of BAX mrna],,,PMID:37414240,https://www.ncbi.nlm.nih.gov/pubmed/37414240,37414240,,
16,196945,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Oxalic acid results in decreased expression of BCL2 mrna|sulfaphenazole inhibits the reaction [oxalic acid results in decreased expression of BCL2 mrna]|[butyric acid co-treated with sulfaphenazole] inhibits the reaction [oxalic acid results in decreased expression of BCL2 mrna],,,PMID:37414240,https://www.ncbi.nlm.nih.gov/pubmed/37414240,37414240,,
17,197538,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),[butyric acid co-treated with sulfaphenazole] inhibits the reaction [oxalic acid results in increased expression of CASP3 mrna]|oxalic acid results in increased expression of CASP3 mrna|sulfaphenazole inhibits the reaction [oxalic acid results in increased expression of CASP3 mrna],,,PMID:37414240,https://www.ncbi.nlm.nih.gov/pubmed/37414240,37414240,,
18,197539,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),Oxalic acid results in decreased activity of CAT protein,,,PMID:24145091,https://www.ncbi.nlm.nih.gov/pubmed/24145091,24145091,,
19,197540,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Oxalic acid results in increased expression of CCL2 mRNA,,,PMID:24145091|PMID:37414240,https://www.ncbi.nlm.nih.gov/pubmed/24145091|https://www.ncbi.nlm.nih.gov/pubmed/37414240,24145091|37414240,,
20,197541,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [oxalic acid results in increased expression of CCL2 mrna],,,PMID:24145091,https://www.ncbi.nlm.nih.gov/pubmed/24145091,24145091,,
21,197542,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,1535,CYBA,https://ctdbase.org/detail.go?type=gene&acc=1535,,,1535.0,CYBA,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [oxalic acid results in increased expression of CYBA mrna]|oxalic acid results in increased expression of CYBA mRNA,,,PMID:24145091,https://www.ncbi.nlm.nih.gov/pubmed/24145091,24145091,,
22,197543,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,4199,ME1,https://ctdbase.org/detail.go?type=gene&acc=4199,,,4199.0,ME1,8930.0,Columbidae (pigeons),[malic acid co-treated with manganese chloride co-treated with NADP] inhibits the reaction [oxalic acid binds to ME1 protein]|nadp promotes the reaction [oxalic acid binds to ME1 protein]|oxalic acid binds to ME1 protein,,,PMID:7356971,https://www.ncbi.nlm.nih.gov/pubmed/7356971,7356971,,
23,197544,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,653361,NCF1,https://ctdbase.org/detail.go?type=gene&acc=653361,,,653361.0,NCF1,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [oxalic acid results in increased expression of NCF1 mrna]|oxalic acid results in increased expression of NCF1 mRNA,,,PMID:24145091,https://www.ncbi.nlm.nih.gov/pubmed/24145091,24145091,,
24,197545,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,10861,SLC26A1,https://ctdbase.org/detail.go?type=gene&acc=10861,,,10861.0,SLC26A1,9606.0,Homo sapiens (human),SLC26A1 protein results in increased secretion of oxalic acid,,,PMID:19002488,https://www.ncbi.nlm.nih.gov/pubmed/19002488,19002488,,
25,197546,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,65010,SLC26A6,https://ctdbase.org/detail.go?type=gene&acc=65010,,,65010.0,SLC26A6,9606.0,Homo sapiens (human),SLC26A6 protein results in increased secretion of oxalic acid,,,PMID:19002488,https://www.ncbi.nlm.nih.gov/pubmed/19002488,19002488,,
26,197547,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9606.0,Homo sapiens (human),Oxalic acid results in increased expression of SPP1 mRNA,,,PMID:24145091|PMID:37414240,https://www.ncbi.nlm.nih.gov/pubmed/24145091|https://www.ncbi.nlm.nih.gov/pubmed/37414240,24145091|37414240,,
27,197999,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [oxalic acid results in increased expression of SPP1 mrna],,,PMID:24145091,https://www.ncbi.nlm.nih.gov/pubmed/24145091,24145091,,
28,198000,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [oxalic acid results in increased expression of TGFB1 protein]|oxalic acid results in increased expression of TGFB1 protein,,,PMID:24145091,https://www.ncbi.nlm.nih.gov/pubmed/24145091,24145091,,
29,198001,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,7046,TGFBR1,https://ctdbase.org/detail.go?type=gene&acc=7046,,,7046.0,TGFBR1,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [oxalic acid results in increased expression of TGFBR1 protein]|oxalic acid results in increased expression of TGFBR1 protein,,,PMID:24145091,https://www.ncbi.nlm.nih.gov/pubmed/24145091,24145091,,
30,198002,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D019815,Oxalic Acid,https://ctdbase.org/detail.go?type=chem&acc=D019815,7048,TGFBR2,https://ctdbase.org/detail.go?type=gene&acc=7048,,,7048.0,TGFBR2,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [oxalic acid results in increased expression of TGFBR2 protein],,,PMID:24145091,https://www.ncbi.nlm.nih.gov/pubmed/24145091,24145091,,
31,198003,971,Toxin and Toxin Target Database (T3DB),Oxalic Acid,T3D0856,Oxalic acid,http://www.t3db.ca/toxins/T3D0856,BE0000838,Proto-oncogene tyrosine-protein kinase Src,http://www.t3db.ca/biodb/bio_entities/BE0000838,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
32,198004,971,Toxin and Toxin Target Database (T3DB),Oxalic Acid,T3D0856,Oxalic acid,http://www.t3db.ca/toxins/T3D0856,BE0000048,Prothrombin,http://www.t3db.ca/biodb/bio_entities/BE0000048,P00734,Prothrombin,2147.0,F2,9606.0,Homo sapiens (human),"Oxalic acid binds to the prothrombin promoter, inhibiting the formation of thromboxane B2 from arachidonic acid. (A218)(A219)",,,PMID:16320015|PMID:6320905,https://www.ncbi.nlm.nih.gov/pubmed/16320015|https://www.ncbi.nlm.nih.gov/pubmed/6320905,16320015|6320905,,
33,198005,971,Toxin and Toxin Target Database (T3DB),Oxalic Acid,T3D0856,Oxalic acid,http://www.t3db.ca/toxins/T3D0856,BE0002252,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002252,O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",6392.0,SDHD,9606.0,Homo sapiens (human),Oxalic acid is a competitive inhibitor of succinate dehydrogenase. (A220),,,PMID:6318974,https://www.ncbi.nlm.nih.gov/pubmed/6318974,6318974,,
34,198006,971,Toxin and Toxin Target Database (T3DB),Oxalic Acid,T3D0856,Oxalic acid,http://www.t3db.ca/toxins/T3D0856,BE0000176,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0000176,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",6389.0,SDHA,9606.0,Homo sapiens (human),Oxalic acid is a competitive inhibitor of succinate dehydrogenase. (A220),,,PMID:6318974,https://www.ncbi.nlm.nih.gov/pubmed/6318974,6318974,,
35,198007,971,Toxin and Toxin Target Database (T3DB),Oxalic Acid,T3D0856,Oxalic acid,http://www.t3db.ca/toxins/T3D0856,BE0002254,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0002254,P21912,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",6390.0,SDHB,9606.0,Homo sapiens (human),Oxalic acid is a competitive inhibitor of succinate dehydrogenase. (A220),,,PMID:6318974,https://www.ncbi.nlm.nih.gov/pubmed/6318974,6318974,,
36,370407,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Calcium oxalate results in increased expression of BAX protein|sirt1 protein inhibits the reaction [calcium oxalate results in increased expression of BAX protein],,,PMID:34333021,https://www.ncbi.nlm.nih.gov/pubmed/34333021,34333021,,
37,370408,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),SIRT1 protein inhibits the reaction [calcium oxalate results in decreased expression of BCL2 protein]|calcium oxalate results in decreased expression of BCL2 protein,,,PMID:34333021,https://www.ncbi.nlm.nih.gov/pubmed/34333021,34333021,,
38,370409,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9615.0,Canis lupus familiaris (dog),Diosgenin inhibits the reaction [calcium oxalate results in increased activity of CASP3 protein]|calcium oxalate results in increased activity of CASP3 protein,,,PMID:25446497,https://www.ncbi.nlm.nih.gov/pubmed/25446497,25446497,,
39,370479,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Calcium oxalate results in increased cleavage of CASP3 protein|sirt1 protein inhibits the reaction [calcium oxalate results in increased cleavage of CASP3 protein],,,PMID:34333021,https://www.ncbi.nlm.nih.gov/pubmed/34333021,34333021,,
40,370480,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9615.0,Canis lupus familiaris (dog),Calcium oxalate results in increased activity of CASP9 protein|diosgenin inhibits the reaction [calcium oxalate results in increased activity of CASP9 protein],,,PMID:25446497,https://www.ncbi.nlm.nih.gov/pubmed/25446497,25446497,,
41,370481,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),2-aminoethyl diphenylborinate inhibits the reaction [calcium oxalate results in decreased expression of CAT protein]|calcium oxalate results in decreased expression of CAT protein,,,PMID:37454925,https://www.ncbi.nlm.nih.gov/pubmed/37454925,37454925,,
42,370482,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116.0,Rattus norvegicus (Norway rat),2-aminoethyl diphenylborinate inhibits the reaction [calcium oxalate results in decreased expression of CCL2 protein]|calcium oxalate results in decreased expression of CCL2 protein,,,PMID:37454925,https://www.ncbi.nlm.nih.gov/pubmed/37454925,37454925,,
43,370483,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116.0,Rattus norvegicus (Norway rat),[ethylene glycol co-treated with calcium oxalate] results in increased expression of CCL2 protein|sulfaphenazole inhibits the reaction [oxalic acid results in increased expression of CCL2 mrna]|butyric acid inhibits the reaction [[ethylene glycol co-treated with calcium oxalate] results in increased expression of CCL2 mrna]|[ethylene glycol co-treated with calcium oxalate] results in increased expression of CCL2 mrna|butyric acid inhibits the reaction [[ethylene glycol co-treated with calcium oxalate] results in increased expression of CCL2 protein]|[butyric acid co-treated with sulfaphenazole] inhibits the reaction [oxalic acid results in increased expression of CCL2 mrna],,,PMID:37414240,https://www.ncbi.nlm.nih.gov/pubmed/37414240,37414240,,
44,370484,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,960,CD44,https://ctdbase.org/detail.go?type=gene&acc=960,,,960.0,CD44,10116.0,Rattus norvegicus (Norway rat),2-aminoethyl diphenylborinate inhibits the reaction [calcium oxalate results in decreased expression of CD44 protein]|calcium oxalate results in decreased expression of CD44 protein,,,PMID:37454925,https://www.ncbi.nlm.nih.gov/pubmed/37454925,37454925,,
45,370485,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,960,CD44,https://ctdbase.org/detail.go?type=gene&acc=960,,,960.0,CD44,10116.0,Rattus norvegicus (Norway rat),Butyric acid inhibits the reaction [[ethylene glycol co-treated with calcium oxalate] results in increased expression of CD44 mrna]|[ethylene glycol co-treated with calcium oxalate] results in increased expression of CD44 protein|[ethylene glycol co-treated with calcium oxalate] results in increased expression of CD44 mrna|[butyric acid co-treated with sulfaphenazole] inhibits the reaction [oxalic acid results in increased expression of CD44 mrna]|sulfaphenazole inhibits the reaction [oxalic acid results in increased expression of CD44 mrna]|oxalic acid results in increased expression of CD44 mrna|butyric acid inhibits the reaction [[ethylene glycol co-treated with calcium oxalate] results in increased expression of CD44 protein],,,PMID:37414240,https://www.ncbi.nlm.nih.gov/pubmed/37414240,37414240,,
46,370486,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,10116.0,Rattus norvegicus (Norway rat),Butyric acid inhibits the reaction [oxalic acid results in increased expression of CYP2C9 mrna]|[ethylene glycol co-treated with calcium oxalate] results in increased expression of CYP2C9 mrna|butyric acid inhibits the reaction [[ethylene glycol co-treated with calcium oxalate] results in increased expression of CYP2C9 mrna]|[butyric acid co-treated with sulfaphenazole] inhibits the reaction [oxalic acid results in increased expression of CYP2C9 mrna]|sulfaphenazole inhibits the reaction [oxalic acid results in increased expression of CYP2C9 mrna]|oxalic acid results in increased expression of CYP2C9 mRNA,,,PMID:37414240,https://www.ncbi.nlm.nih.gov/pubmed/37414240,37414240,,
47,371058,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,2677,GGCX,https://ctdbase.org/detail.go?type=gene&acc=2677,,,2677.0,GGCX,9606.0,Homo sapiens (human),Calcium oxalate results in increased activity of GGCX protein,,,PMID:9471053,https://www.ncbi.nlm.nih.gov/pubmed/9471053,9471053,,
48,371059,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,3065,HDAC1,https://ctdbase.org/detail.go?type=gene&acc=3065,,,3065.0,HDAC1,10116.0,Rattus norvegicus (Norway rat),Oxalic acid results in increased expression of HDAC1 mrna|butyric acid inhibits the reaction [[ethylene glycol co-treated with calcium oxalate] results in increased expression of HDAC1 mrna]|butyric acid inhibits the reaction [oxalic acid results in increased expression of HDAC1 mrna]|[ethylene glycol co-treated with calcium oxalate] results in increased expression of HDAC1 mRNA,,,PMID:37414240,https://www.ncbi.nlm.nih.gov/pubmed/37414240,37414240,,
49,371060,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,3066,HDAC2,https://ctdbase.org/detail.go?type=gene&acc=3066,,,3066.0,HDAC2,10116.0,Rattus norvegicus (Norway rat),Oxalic acid results in increased expression of HDAC2 mrna|butyric acid inhibits the reaction [oxalic acid results in increased expression of HDAC2 mrna]|butyric acid inhibits the reaction [[ethylene glycol co-treated with calcium oxalate] results in increased expression of HDAC2 mrna]|[ethylene glycol co-treated with calcium oxalate] results in increased expression of HDAC2 mRNA,,,PMID:37414240,https://www.ncbi.nlm.nih.gov/pubmed/37414240,37414240,,
50,371061,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,8841,HDAC3,https://ctdbase.org/detail.go?type=gene&acc=8841,,,8841.0,HDAC3,10116.0,Rattus norvegicus (Norway rat),[ethylene glycol co-treated with calcium oxalate] results in increased expression of HDAC3 mrna|butyric acid inhibits the reaction [oxalic acid results in increased expression of HDAC3 mrna]|oxalic acid results in increased expression of HDAC3 mrna|butyric acid inhibits the reaction [[ethylene glycol co-treated with calcium oxalate] results in increased expression of HDAC3 mrna],,,PMID:37414240,https://www.ncbi.nlm.nih.gov/pubmed/37414240,37414240,,
51,371062,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,55869,HDAC8,https://ctdbase.org/detail.go?type=gene&acc=55869,,,55869.0,HDAC8,10116.0,Rattus norvegicus (Norway rat),Oxalic acid results in increased expression of HDAC8 mrna|[ethylene glycol co-treated with calcium oxalate] results in increased expression of HDAC8 mrna|butyric acid inhibits the reaction [[ethylene glycol co-treated with calcium oxalate] results in increased expression of HDAC8 mrna]|butyric acid inhibits the reaction [oxalic acid results in increased expression of HDAC8 mrna],,,PMID:37414240,https://www.ncbi.nlm.nih.gov/pubmed/37414240,37414240,,
52,371063,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Phenyl-N-tert-butylnitrone inhibits the reaction [calcium oxalate results in increased expression of HMOX1 protein]|calcium oxalate results in increased expression of HMOX1 protein,,,PMID:34333021,https://www.ncbi.nlm.nih.gov/pubmed/34333021,34333021,,
53,371064,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,3708,ITPR1,https://ctdbase.org/detail.go?type=gene&acc=3708,,,3708.0,ITPR1,10116.0,Rattus norvegicus (Norway rat),Losartan inhibits the reaction [calcium oxalate results in increased expression of ITPR1 protein]|calcium oxalate results in increased expression of ITPR1 protein,,,PMID:37454925,https://www.ncbi.nlm.nih.gov/pubmed/37454925,37454925,,
54,371065,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,3709,ITPR2,https://ctdbase.org/detail.go?type=gene&acc=3709,,,3709.0,ITPR2,10116.0,Rattus norvegicus (Norway rat),Losartan inhibits the reaction [calcium oxalate results in increased expression of ITPR2 protein]|calcium oxalate results in increased expression of ITPR2 protein,,,PMID:37454925,https://www.ncbi.nlm.nih.gov/pubmed/37454925,37454925,,
55,371659,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,3710,ITPR3,https://ctdbase.org/detail.go?type=gene&acc=3710,,,3710.0,ITPR3,10116.0,Rattus norvegicus (Norway rat),Calcium oxalate results in increased expression of ITPR3 protein,,,PMID:37454925,https://www.ncbi.nlm.nih.gov/pubmed/37454925,37454925,,
56,371660,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,100169685,NOX2,https://ctdbase.org/detail.go?type=gene&acc=100169685,,,100169685.0,,10116.0,Rattus norvegicus (Norway rat),Calcium oxalate results in increased expression of NOX2 protein|2-aminoethyl diphenylborinate inhibits the reaction [calcium oxalate results in increased expression of NOX2 protein],,,PMID:37454925,https://www.ncbi.nlm.nih.gov/pubmed/37454925,37454925,,
57,371661,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,50507,NOX4,https://ctdbase.org/detail.go?type=gene&acc=50507,,,50507.0,NOX4,10116.0,Rattus norvegicus (Norway rat),Calcium oxalate results in increased expression of NOX4 protein|2-aminoethyl diphenylborinate inhibits the reaction [calcium oxalate results in increased expression of NOX4 protein],,,PMID:37454925,https://www.ncbi.nlm.nih.gov/pubmed/37454925,37454925,,
58,371662,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,9606.0,Homo sapiens (human),SIRT1 protein inhibits the reaction [calcium oxalate results in increased expression of BAX protein]|calcium oxalate results in decreased expression of SIRT1 protein|phenyl-N-tert-butylnitrone inhibits the reaction [calcium oxalate results in decreased expression of SIRT1 protein]|sirt1 protein inhibits the reaction [calcium oxalate results in increased cleavage of CASP3 protein]|sirt1 protein inhibits the reaction [calcium oxalate results in decreased expression of BCL2 protein],,,PMID:34333021,https://www.ncbi.nlm.nih.gov/pubmed/34333021,34333021,,
59,371663,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116.0,Rattus norvegicus (Norway rat),2-aminoethyl diphenylborinate inhibits the reaction [calcium oxalate results in decreased expression of SOD1 protein]|calcium oxalate results in decreased expression of SOD1 protein,,,PMID:37454925,https://www.ncbi.nlm.nih.gov/pubmed/37454925,37454925,,
60,371664,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10116.0,Rattus norvegicus (Norway rat),2-aminoethyl diphenylborinate inhibits the reaction [calcium oxalate results in decreased expression of SPP1 protein]|calcium oxalate results in decreased expression of SPP1 protein,,,PMID:37454925,https://www.ncbi.nlm.nih.gov/pubmed/37454925,37454925,,
61,371665,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10116.0,Rattus norvegicus (Norway rat),Butyric acid inhibits the reaction [[ethylene glycol co-treated with calcium oxalate] results in increased expression of SPP1 mrna]|sulfaphenazole inhibits the reaction [oxalic acid results in increased expression of SPP1 mrna]|[ethylene glycol co-treated with calcium oxalate] results in increased expression of SPP1 mrna|[ethylene glycol co-treated with calcium oxalate] results in increased expression of SPP1 protein|[butyric acid co-treated with sulfaphenazole] inhibits the reaction [oxalic acid results in increased expression of SPP1 mrna]|butyric acid inhibits the reaction [[ethylene glycol co-treated with calcium oxalate] results in increased expression of SPP1 protein],,,PMID:37414240,https://www.ncbi.nlm.nih.gov/pubmed/37414240,37414240,,
62,371666,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,7082,TJP1,https://ctdbase.org/detail.go?type=gene&acc=7082,,,7082.0,TJP1,9615.0,Canis lupus familiaris (dog),Calcium oxalate results in decreased expression of TJP1 protein,,,PMID:34147488|PMID:36349591,https://www.ncbi.nlm.nih.gov/pubmed/34147488|https://www.ncbi.nlm.nih.gov/pubmed/36349591,34147488|36349591,,
63,372197,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,7082,TJP1,https://ctdbase.org/detail.go?type=gene&acc=7082,,,7082.0,TJP1,9615.0,Canis lupus familiaris (dog),Docetaxel inhibits the reaction [calcium oxalate results in decreased expression of TJP1 protein],,,PMID:36349591,https://www.ncbi.nlm.nih.gov/pubmed/36349591,36349591,,
64,372198,971,Comparative Toxicogenomics Database (CTD),Oxalic Acid,D002129,Calcium Oxalate,https://ctdbase.org/detail.go?type=chem&acc=D002129,7082,TJP1,https://ctdbase.org/detail.go?type=gene&acc=7082,,,7082.0,TJP1,9615.0,Canis lupus familiaris (dog),Phalloidine inhibits the reaction [calcium oxalate results in decreased expression of TJP1 protein],,,PMID:34147488,https://www.ncbi.nlm.nih.gov/pubmed/34147488,34147488,,
